Paul Tudor Jones Standard Biotools Inc. Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $77,127 - $134,318	-52,468 Reduced 38.15%	85,058 $164,000
Q1 2023 May 15, 2023	SELL	$1.3 - $2.24 $71,644 - $123,448	-55,111 Reduced 28.61%	137,526 $268,000
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $140,156 - $349,516	87,598 Added 83.4%	192,637 $308,000
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $45,385 - $64,187	-16,209 Reduced 13.37%	105,039 $377,000
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $440,130 - $743,250	121,248 New	121,248 $475,000
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $118,673 - $264,176	-51,597 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $154,141 - $404,497	33,292 Added 181.87%	51,597 $239,000
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $210,324 - $259,381	18,305 New	18,305 $226,000
Q1 2019 May 15, 2019	SELL	$8.47 - $14.36 $410,075 - $695,239	-48,415 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $347,619 - $427,504	48,415 New	48,415 $417,000

142

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.